Eyal Attar, M.D.

Eyal Attar, M.D.

Chief Medical OfficeratVor Biopharma· In proxies 2023–2024

Pay in FY2023Vor Biopharma stock -66.2% the same year

Eyal Attar, M.D. was paid $1.4M in FY2023 (Dec). Vor Biopharma stock fell 66.2% that year.

Pay$100 in the stock at the end of FY22 → $34
Pay is from the Summary Compensation Table of each Vor Biopharma proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Vor BiopharmaPublic company · 3 yr
    • Chief Medical Officer2023 – Present · 3 yrStock in role -84%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?